$OLLI had a big day yesterday, rising 15% on the back of strong Q3 numbers. $OLLI still has room to run as it is still down 32% off its 52-week highs. Here are the highlights from Q3: Ollie's Bargain Outlet Holdings (NASDAQ:OLLI) is higher after comparable sales fall by 1.4% in Q3 to miss the consensus estimate for a 1.1% drop, but the company's top line and...
$GLUU is breaking out of its wedge and we see this as bullish. After disappointing Q3 earnings, the stock has held up well and we believe higher prices are in order. Here are the highlights of the November 6 report: Glu Mobile (NASDAQ:GLUU) has tumbled 14% after hours following Q3 results where revenues and losses came in worse than expected. Bookings hit a Q3...
$AMAT remains firmly in an uptrend and the dip looks to be a buying opportunity. Applied Materials, Inc. provides manufacturing equipment, services, and software to the semiconductor, display, and related industries. It operates through three segments: Semiconductor Systems, Applied Global Services, and Display and Adjacent Markets. The Semiconductor Systems...
$MNK has been badly beaten up over the opioid crisis. It's been a favorite of the shorts and they have banked 77% ytd. However, we think judging by the chart, that $MNK has turned the corner and is set to keep climbing. Shorts can help this climb as 55% of the float has been sold short. We could see a massive short covering rally. The latest news is Mallinckrodt...
$SCHW going to commission-free trading has plunged $AMTD down 20% at Tuesday's open. Good opportunity to buy the dip in $AMTD. Selloff overdone. As always, trade with caution and use protective stops. Good luck to all!
$MDCO has been having a banner year with the stock up over 200%. We think this rally still has legs and that $MDCO is going to keep climbing after Monday's huge breakout. Here's a look at what drove Monday's breakout. Results from a Phase 3 clinical trial, ORION-9, evaluating the effect of The Medicines Company's (MDCO +2.3%) inclisiran on reducing "bad"...
$BBCP has caught our attention to what we see as a rounding bottom. The stock has been slowly climbing up the ladder and we think $BBCP has potential to keep climbing. On the fundamental side, insiders own 45% of the company and that caught our attention as well. $BBCP looks to be a nice setup at current levels. Concrete Pumping Holdings, Inc. provides concrete...
$STNE is set to keep climbing after breaking out to the upside on Friday. The company delivered strong Q3 results and $BRK-B has a 7.9% stake in the company. Here are the highlights: StoneCo (NASDAQ:STNE) Q3 total revenue and income of R$671.1M (US$159M) jumped 60% from the year-ago quarter. Q3 adjusted net income of R$201.9M rose 126% Y/Y. Q3 adjusted net...
$BKE delivered a strong Q3 earnings report and the stock gapped and made new 52-week highs. With 35% of the float short, we believe $BKE is set to keep climbing as the shorts get squeezed. Here are the highlights from Q3: Buckle (NYSE:BKE): Q3 GAAP EPS of $0.53 beats by $0.10. Revenue of $224.12M (+4.2% Y/Y) beats by $6.34M. Buckle reported a comparable sales...
$CREE is under pressure technically and broke under a key uptrend line. Just looking at the chart and you can see that $CREE has been making lower highs and lows. We believe $CREE is going under $40 and will test new 52 week lows. This all comes after $CREE delivered disappointing Q1 earnings and forecast a loss in Q2. Here are the highlights: Cree (NASDAQ:CREE)...
$IDT has served us well in the past when we caught the move from $8.29 to highs over $11 for a quick 37% gain. Now, after $IDT has sold off, we think the low is in and the stock is set to climb again. IDT Corporation operates primarily in the telecommunications and payment industries in the United States and internationally. The company operates in two segments,...
While most cannabis names have broken trend line support, $VFF support is still in tact. We are now seeing a nice bounce in $VFF and one which we think will continue. $VFF is one of the strongest cannabis players in the space and will be a market leader when the cannabis bear market is over. Some highlights of why to be Long $VFF: *actually profitable with other...
$CLDR continues to climb and just broke out of its wedge. We first alerted our subscribers back in August when $CLDR was just $6.60 a share. Since that time, subscribers are sitting on gains of 42% and we believe there's much more to be had. Cloudera, Inc. provides a suite of data analytics and management products in the United States, Europe, and Asia. The...
$WW has been a roller coaster ride for investors. After dropping to as low as $16.71, the stock is back above $40. For the year, the stock is up only 4%. We think the stock is set to keep climbing judging from the chart and how investors reacted to its Q3 earnings report. While the stock gapped down, it has since closed the gap and is now trading higher. We...
$CLCT looks set to fall to the $22 support level, right where the 200 day moving average is. The stock has multiple tops at the $30 level and what can't go higher, must go lower. After all, $CLCT is up 129% ytd and we expect nervous longs to book profits. Collectors Universe, Inc. provides authentication and grading services to dealers and collectors of coins,...
$URBN has broken key trend line support and is set for lower prices. Add in the overwhelming bearish sentiment among retailers and we could go a lot lower than investors think. After reporting Q3 earnings last night, here are the highlights: Urban Outfitters (NASDAQ:URBN) slides after a slight miss with its Q3 report. Comparable retail segment net sales rose 3%...
$CCMP broke the uptrend yesterday and the stock crashed hard. For those that want to buy the dip, we advise not to. We think further weakness is ahead after yesterday's technical damage. The earliest near-term support we see is around $125. Besides the technicals, $CCMP issued soft guidance, so the fundamentals don't support a higher price as well. Here are the...
$KRTX exploded up the charts on Monday rising 442%. This was clearly a short squeeze and we told our followers as such. After squeezing the shorts, $KRTX is out with an offering and raising money like all biotechs do on a big run. Now, it's the bagholders turn to get screwed over. Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily...